Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I8SK
|
|||
Former ID |
DIB020220
|
|||
Drug Name |
L-isoleucine
|
|||
Synonyms |
l-isoleucine; Isoleucine; 73-32-5; (2S,3S)-2-Amino-3-methylpentanoic acid; H-Ile-OH; (S)-Isoleucine; 2S,3S-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; erythro-L-Isoleucine; L-(+)-Isoleucine; L-Ile; alpha-Amino-beta-methylvaleric acid; 443-79-8; Isoleucine (VAN); Isoleucinum [Latin]; Isoleucina [Spanish]; Valeric acid, 2-amino-3-methyl-; Norvaline, 3-methyl-; L-Norvaline, 3-methyl-, erythro-; ISOLEUCINE, L-; Acetic acid, amino-sec-butyl-; Pentanoic acid, 2-amino-3-methyl-; CCRIS 5229; iso-leucine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C6H13NO2
|
|||
Canonical SMILES |
CCC(C)C(C(=O)O)N
|
|||
InChI |
1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1
|
|||
InChIKey |
AGPKZVBTJJNPAG-WHFBIAKZSA-N
|
|||
CAS Number |
CAS 443-79-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
3697, 595255, 841560, 3134463, 7847133, 7888358, 8025198, 8138262, 8143658, 8153977, 10317510, 10317646, 15170678, 15297247, 24881234, 24896006, 24896013, 24896065, 24896115, 24902116, 29225298, 46506864, 49835902, 49985788, 57323334, 57578213, 57578215, 57651663, 57654304, 76061775, 81044539, 81067322, 85164889, 85176936, 85267076, 85291370, 87350314, 87571564, 92298276, 99215114, 99453073, 103059667, 104249752, 104311679, 117397136, 117397137, 117689351, 118264757, 124384995, 124580847
|
|||
ChEBI ID |
CHEBI:17191
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3311). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.